The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.

Overview of attention for article published in Journal of Rheumatology, February 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy: 2 policy sources

patent: 1 patent

Citations

dimensions_citation: 243 Dimensions

Readers on

mendeley: 118 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain : J: Pharmacological management for chronic primary pain

Cited by National Institute for Health and Care Excellence on 06 Apr 2021

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Fibromyalgiesyndrom: Definition, Pathophysiologie, Diagnostik und Therapie: Complete guideline: Fibromyalgia syndrome: Definition, classification, clinical diagnosis and prognosis

Cited by The Association of the Scientific Medical Societies in Germany on 04 Jan 2012

The Association of the Scientific Medical Societies in Germany (AWMF) is an umbrella organization of over 150 societies, and advises the government of the Federal Republic of Germany as well as the governments of the German federal countries in all topics of scientific medicine and medical research and classification.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.